Larimar Therapeutics, Inc. (LRMR) Social Stream



Larimar Therapeutics, Inc. (LRMR): $2.15

0.19 (+9.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LRMR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 413

in industry

Larimar Therapeutics Inc (LRMR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LRMR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $26.43 $19 $22.715 $3.85 490%
2022-02-15 2 $26.43 $3 $14.715 $3.85 282.21%

The Trend in the Analyst Price Target


Over the past 27 months, LRMR's average price target has gone up $5.36.

LRMR reports an average of 134.98% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 2 30.00 19 24.500 10.35 136.71%
2021-08-07 2 30.00 19 24.500 10.70 128.97%
2021-08-09 2 30.00 19 24.500 10.23 139.49%
2021-11-12 2 26.43 19 22.715 11.41 99.08%
2022-02-15 2 26.43 3 14.715 4.01 266.96%

LRMR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 123 days, LRMR's average broker recommendation rating worsened by 1.33.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Larimar Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 380.36% of them.
  • Larimar Therapeutics Inc's number of analysts covering the stock is greater than 20.56% of all US stocks.
  • Larimar Therapeutics Inc's variance in analysts' estimates is lower than -71.42% of Pharmaceutical Products stocks.
  • In terms of how Larimar Therapeutics Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 136.4% of that group.

Stocks similar to Larimar Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LPCN, LMNL, and LIAN.

What is the outlook for LRMR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5141 seconds.